Literature DB >> 811555

Naturally occurring double-stranded RNA and immune responses. III. Immunogenicity and antigenicity in animals.

P G Cunningham, J D Naysmith.   

Abstract

Naturally occurring, double-stranded RNA (ds-RNA)) was immunogenic when injected into mice, rats, guinea-pigs, rabbits, dogs and baboons. The response to native material administered intravenously (i.v.) was strongest in rabbits and mice, and weakest in baboons. Mice, guinea-pigs and baboons injected with ds-RNA complexed with methylated BSA emulsified in Freund's complete adjuvant all gave high antibody responses. When ds-RNA was given in aerosol form to mice and guinea-pigs the response was weaker than that following i.v. injection, and baboons did not respond to antigen given as an aerosol. In most species the immune response obtained was predominantly IgM in nature, and there was no evidence for cell-mediated immunity in any species. The only evidence of an adverse reaction associated with repeated administration of ds-RNA was a systemic anaphylactic-type response in a small group of mice given ds-RNA repeatedly in aerosol form and challenged with ds-RNA i.v.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 811555      PMCID: PMC1446031     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Immune response of mice to nucleic acids: strain-dependent differences in magnitude and class of antibody production.

Authors:  B D Stollar; S Fuchs; E Mozes
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

2.  Resistance to virus infection during the hyporeactive state of interferon induction.

Authors:  T J Sharpe; P J Birch; D N Planterose
Journal:  J Gen Virol       Date:  1971-09       Impact factor: 3.891

3.  The anti-virus activity of double-stranded RNA in the presence of antibody to double-stranded RNA.

Authors:  J D Naysmith; T J Sharpe; D N Planterose
Journal:  Eur J Immunol       Date:  1974-09       Impact factor: 5.532

4.  Specificity of anti-poly G-poly C antibodies.

Authors:  E Nahon-Merlin; A M Michelson; C Verger; F Lacour
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

5.  Genesis of antinuclear antibody in NZB-W mice: role of genetic factors and of viral infections.

Authors:  P H Lambert; F J Dixon
Journal:  Clin Exp Immunol       Date:  1970-06       Impact factor: 4.330

6.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

7.  The potentiating effect of an interferon inducer (BRL 5907) on oil based inactivated Newcastle disease vaccine.

Authors:  R E Gough; W H Allan; D J Knight; J W Leiper
Journal:  Res Vet Sci       Date:  1974-11       Impact factor: 2.534

8.  The antibody response to polyinosinic polycytidylic acid.

Authors:  L M Parker; A D Steinberg
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

9.  [Antigenicity of polynucleotide complexes].

Authors:  E Nahon; A M Michelson; F Lacour
Journal:  Biochim Biophys Acta       Date:  1967-11-21

10.  Immunochemical detection of double-stranded ribonucleic acid in leaves of sugar cane infected with Fiji disease virus.

Authors:  R I Francki; A O Jackson
Journal:  Virology       Date:  1972-04       Impact factor: 3.616

View more
  2 in total

1.  Antibody repertoire development in fetal and neonatal piglets. XVI. Influenza stimulates adaptive immunity, class switch and diversification of the IgG repertoire encoded by downstream Cγ genes.

Authors:  John E Butler; XiuZhu Sun; Nancy Wertz; Amy L Vincent; Eraldo L Zanella; Kelly M Lager
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

2.  The porcine antibody repertoire: variations on the textbook theme.

Authors:  John E Butler; Nancy Wertz
Journal:  Front Immunol       Date:  2012-06-27       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.